Send to

Choose Destination
Ann Biomed Eng. 1989;17(6):633-46.

Pharmacokinetic modeling of ethyl loflazepate (Victan) and its main active metabolites.

Author information

INSERM U 278, Faculty of Pharmacy, Marseilles, France.


A simultaneous consideration of plasma and urine data of unchanged drug and active metabolites, taking into account the metabolic process of the precursor, is described. The maximum likelihood principle was used to estimate parameters. This methodology is highly efficient in determining the contribution of the two main and active metabolites in the pharmacological response of ethyl loflazepate. It also may serve in the search for optimum dosage regimens in clinical practice.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center